June 19, 2017 - June 22, 2017
San Diego, CA
Panelist: Roger Longman
Real Endpoints LLC
Value assessment frameworks are a relatively new concept designed to help stakeholders determine what treatments provide the most value in healthcare. They are sometimes influential in determining what therapies are chosen by patients and their doctors, and often used to determine if those therapies will be covered and reimbursed by payers. How these frameworks consider personalized medicine is not yet clear. Designed before 25% of all new drugs were personalized medicines, value frameworks might need to evolve to keep pace with scientific discovery and recognize the leading role of diagnostic testing in targeting therapeutic use. This session will examine how value assessment frameworks have been developed historically, examine the current critiques of their processes and methodologies and explore how they might have to change in the future to support personalized medicine.
view event >April 28, 2024 - May 2, 2024
Las Vegas, NV
The Real Endpoints team will be on the ground for Asembia’s AXS24 Summit April 28 – May 2 to discuss market access, pricing and contracting, and patient support services.
April 15, 2024 - April 17, 2024
Cambridge, UK
Jeff Berkowtiz, CEO
The ABI conference is an annual invitation-only gathering of industry leaders, scientists and inventors, and innovators that alternates between Cambridge UK and Cambridge US. On April 16, CEO Jeff Berkowitz will present a talk, “Paying for Innovation.”
April 15, 2024 - April 18, 2024
New Orleans, LA
Rob O'Brien, SVP Specialty
On April 17, Rob O’Brien will join payers and thought leaders at this year’s annual AMCP meeting to discuss prescription digital therapeutics and how to prepare for coverage.
January 7, 2024
San Francisco, CA
Jeff Berkowitz, CEO
Real Endpoints
Real Endpoints CEO, Jeff Berkowitz to be participating in the Sachs NIF at JPM24. Given the level of innovation in CNS, it’s a timely discussion.
November 17, 2023
Chicago, IL
Rob O'Brien, SVP Specialty
A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.
October 19, 2023 - October 20, 2023
Las Vegas, NV
Jane Barlow, Chief Clinical Officer
A meeting of healthcare executives representing integrated delivery networks, managed care nurses, and medical directors.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights